On the U.S. Nasdaq market, Moderna (MRNA) is drawing investors' attention with a strong upward trend from the early hours of trading.

As of 10:12 a.m. on the 9th (U.S. local time), Moderna was trading at $214.03, up $17.03 (8.64%) from the previous trading day. It has shown a clear upward trend since the market open, trading above the $210 level.

With the gain exceeding 8%, attention is focused on the future direction of the stock price. In particular, as the rise has been steep in a short period, whether buying interest will hold until the close is seen as a key point to watch. It remains to be seen whether the current strength will continue into the latter half of the session, or whether profit-taking volume will pour in and narrow the gains.

Meanwhile, Moderna is newly included in the Nasdaq-100 index starting today. Nasdaq previously announced that Moderna would be added to the index's constituent stocks, replacing Warner Bros. Discovery. The possibility of changes in supply and demand due to the index inclusion is also a major focus of market interest.

Attention is now on whether the early-session rally will last until the regular market close.

[This article is for informational purposes only regarding investment; investment decisions and any resulting responsibility rest with the investor.]